← Back to Home

What Do Cancer Cells Leave Behind as They Move? Newly Discovered Vesicles Carry DNA and Mitochondria

Researchers have found that migrating cells release vesicles called MoVes from their rear ends, carrying genetic information and organelles from the source cells. Whether this route of material transfer contributes to cancer spread still requires clarification through in vivo studies.

By SURL BioNews

As cancer cells move, they may also leave genetic information behind. A team at the Research Institute of the McGill University Health Centre in Canada has discovered a type of vesicle released from the rear ends of migrating cells that can carry DNA and functional organelles. The finding offers new clues to understanding how cancer cells influence their surroundings, but it has not yet demonstrated that these vesicles contribute to metastasis.

The study was published on October 28 in *Nature Cell Biology*, with Julia Burnier as senior author and Thupten Tsering as first author. The team named these structures motile vesicles, or MoVes. Using live-cell imaging and scanning electron microscopy, they observed vesicles approximately 2 to 5 micrometers in diameter forming and being released as cells migrated forward and their rear ends retracted.

The contents of MoVes add another layer of significance to the trail left by moving cells. According to the abstract of imaging dataset S-BIAD4052 indexed in OmicsDI, whole-genome sequencing showed that vesicle DNA spanned the source cells’ genomes and reflected their mutational profiles. This finding reveals a route by which genetic material leaves cells, but it does not establish that every vesicle contains a complete, functional genome.

The vesicles also contain mitochondria. The same dataset abstract states that functional experiments showed that the mitochondrial contents carried by MoVes could enhance oxidative phosphorylation in recipient cells, an important process by which cells produce energy. This suggests that their contents may alter the metabolism of other cells. Whether this consequently promotes tumor growth or invasion remains a separate question requiring validation.

A key clue to MoVes formation points to epithelial–mesenchymal transition (EMT), in which cells that were originally tightly connected shift to a more mobile state. CityNews Montreal reported that after the team induced this transition in noncancerous cells, MoVes production increased substantially. This supports a link between vesicle formation, cell state, and migratory behavior, while also cautioning against treating MoVes as a marker unique to cancer cells.

Extracellular vesicles are already one of the routes through which cells exchange molecules. This study focuses more specifically on migration, examining how DNA and organelles are packaged and released. The team will next investigate the mechanisms controlling MoVes formation and release, as well as the changes that occur in cells receiving these contents.

The current evidence comes primarily from in vitro cell-line experiments. Researchers still need to determine whether MoVes can be detected in animal models and patients before they can assess their relationship with cancer progression. The idea of using them as indicators for cancer detection, disease monitoring, or treatment response remains at a research stage requiring validation.

References

  1. McGill University Health Centre
  2. CityNews Montreal
  3. OmicsDI